journal
https://read.qxmd.com/read/33449999/development-of-a-treatment-decision-algorithm-for-hiv-uninfected-children-evaluated-for-pulmonary-tuberculosis
#1
Kenneth S Gunasekera, Elisabetta Walters, Marieke M van der Zalm, Megan Palmer, Joshua L Warren, Anneke C Hesseling, Ted Cohen, James A Seddon
BACKGROUND: Limitations in the sensitivity and accessibility of diagnostic tools for childhood tuberculosis contribute to the substantial gap between estimated cases and cases notified to national tuberculosis programs. Thus, tools to make accurate and rapid clinical diagnoses are necessary to initiate more children on antituberculosis treatment. METHODS: We analyzed data from a prospective cohort of children <13 years being routinely evaluated for pulmonary tuberculosis in Cape Town, South Africa from March 2012 to November 2017...
January 15, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33449997/pneumocystis-jirovecii-pneumonia-and-use-of-mtor-inhibitors-in-kidney-transplantation
#2
Julien Coussement, Oriol Manuel
No abstract text is available yet for this article.
January 15, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33449995/reply-to-coussement-et-al
#3
Hannah Kaminski, Julie Belliere, Lionel Couzi, Nassim Kamar, Pierre Merville
No abstract text is available yet for this article.
January 15, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33449994/reply-to-martin-loeches-et-al
#4
P Lewis White, Rishi Dhillon, Matthew P Wise, Matthijs Backs
No abstract text is available yet for this article.
January 15, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33439971/half-life-defined-as-the-time-until-half-of-the-log-titer-is-not-informative-and-should-be-replaced-with-segments-comment-on-hirose-et-al-2020
#5
Ed J Gracely
No abstract text is available yet for this article.
January 13, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33439965/reply-to-gracely
#6
Ryohei Hirose, Hiroshi Ikegaya, Yuji Naito, Naoto Watanabe, Takuma Yoshida, Risa Bandou, Tomo Daidoji, Yoshito Itoh, Takaaki Nakaya
No abstract text is available yet for this article.
January 13, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33438030/reply-to-meyerowitz-and-richterman
#7
Robert T Schooley, Ferric C Fang
No abstract text is available yet for this article.
January 13, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33433558/a-defense-of-the-classical-model-of-transmission-of-respiratory-pathogens
#8
Eric A Meyerowitz, Aaron Richterman
No abstract text is available yet for this article.
January 12, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33423047/evaluating-antimicrobial-effectiveness-in-environmental-microbiology
#9
Andreas F Widmer, Reno Frei
No abstract text is available yet for this article.
January 10, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33421068/emergence-and-transmission-of-daptomycin-and-vancomycin-resistant-enterococci-between-patients-and-hospital-rooms
#10
Lynn El Haddad, Blake M Hanson, Cesar A Arias, Shashank S Ghantoji, Cynthia P Harb, Mark Stibich, Roy F Chemaly
BACKGROUND: Vancomycin-resistant enterococci (VRE) are a major cause of morbidity and mortality in immunocompromised patients. Tracking the dissemination of VRE strains is crucial to understand the dynamics of emergence and spread of VRE in the hospital setting. METHODS: Whole genome sequencing (WGS) and phylogenetic analyses were performed to identify dominant VRE strains and potential transmission networks between 35 patients with VRE-positive rectal swabs and their rooms (main rooms and bathrooms) on the leukemia (LKM) and the hematopoietic cell transplant (HCT) floors...
January 9, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33421056/confirmed-reinfection-with-sars-cov-2-variant-voc-202012-01
#11
David Harrington, Beatrix Kele, Spiro Pereira, Xose Couto-Parada, Anna Riddell, Suzanne Forbes, Hamish Dobbie, Teresa Cutino-Moguel
No abstract text is available yet for this article.
January 9, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33421055/erratum
#12
(no author information available yet)
No abstract text is available yet for this article.
January 9, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33420788/epidemiology-of-invasive-escherichia-coli-infection-and-antibiotic-resistance-status-among-patients-treated-in-u-s-hospitals-2009-2016
#13
Elizabeth Begier, Ning A Rosenthal, Alejandra Gurtman, Alex Kartashov, Robert G K Donald, Stephen P Lockhart
BACKGROUND: Published data is limited on the prevalence and risk of recurrence of extraintestinal invasive E. coli infections (IEIs) in the United States. METHODS: All inpatient and hospital-based outpatient visits occurring between 2009-2016 at hospitals with continuous microbiology data submission to the Premier Healthcare Database for 90 days prior to the admission/visit and 12 months following it were included in analysis. IEI was defined as having positive E...
January 9, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33417690/rates-of-aspergillus-co-infection-in-covid-patients-in-icu-not-as-high-as-previously-reported
#14
Sean Boyd, Ignacio Martin-Loeches
No abstract text is available yet for this article.
January 8, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33417689/lack-of-sars-cov2-neutralization-by-antibodies-to-seasonal-coronaviruses-making-sense-of-the-covid-19-pandemic
#15
Mikyung Lee
No abstract text is available yet for this article.
January 8, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33417683/the-duration-of-protection-from-azithromycin-against-malaria-acute-respiratory-gastro-intestinal-and-skin-infections-when-given-alongside-seasonal-malaria-chemoprevention-secondary-analyses-of-data-from-a-clinical-trial-in-hound%C3%A3-burkina-faso-and-bougouni-mali
#16
Mphatso Dennis Phiri, Matthew Cairns, Issaka Zongo, Frederic Nikiema, Modibo Diarra, Rakiswendé Serge Yerbanga, Amadou Barry, Amadou Tapily, Samba Coumare, Ismaila Thera, Irene Kuepfer, Paul Milligan, Halidou Tinto, Alassane Dicko, Jean Bosco Ouédraogo, Brian Greenwood, Daniel Chandramohan, Issaka Sagara
BACKGROUND: Mass drug administration (MDA) with azithromycin (AZ) is being considered as a strategy to promote child survival in sub-Saharan Africa, but the mechanism by which AZ reduces mortality is unclear. To better understand the nature and extent of protection provided by AZ, we explored the profile of protection by time since administration, using data from a household-randomised, placebo-controlled trial in Burkina Faso and Mali. METHODS: Between 2014 and 2016, 30,977 children aged 3-59 months received seasonal malaria chemoprevention (SMC) with sulphadoxine-pyrimethamine plus amodiaquine and either AZ or placebo monthly, on four occasions each year...
January 8, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33417679/improving-the-prediction-of-relapse-after-nucleos-t-ide-analogue-discontinuation-in-patients-with-chronic-hepatitis-b
#17
Do Seon Song, Jeong Won Jang, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
BACKGROUND: Current guidelines recommend rules for stopping nucleos(t)ide analogues (NAs) in chronic hepatitis B (CHB) patients, but off-therapy relapse is still high. This study aimed to identify predictors of off-therapy relapse and improve existing stopping rules. METHODS: This retrospective study included 488 CHB patients (262 HBeAg-positive and 226 HBeAg-negative) who discontinued NAs. Post-treatment relapse was investigated. RESULTS: During the median follow-up period of 73...
January 8, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33411907/use-of-an-electronic-medical-record-alert
#18
Harold Horowitz
No abstract text is available yet for this article.
January 7, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33411901/does-partner-treatment-impact-on-bv-cure
#19
Lenka A Vodstrcil, Catriona S Bradshaw
No abstract text is available yet for this article.
January 7, 2021: Clinical Infectious Diseases
https://read.qxmd.com/read/33411899/evolution-of-cefiderocol-non-susceptibility-in-pseudomonas-aeruginosa-in-a-patient-without-previous-exposure-to-the-antibiotic
#20
Ana Paula Streling, Mohanad M Al Obaidi, William D Lainhart, Tirdad Zangeneh, Ayesha Khan, An Q Dinh, Blake Hanson, Cesar A Arias, William R Miller
We report the emergence of non-susceptibility to cefiderocol from a subpopulation of Pseudomonas aeruginosa recovered from a patient without history of cefiderocol exposure. Whole genome sequencing identified mutations in major iron transport pathways previously associated with cefiderocol uptake. Susceptibility testing should be performed before therapy with siderophore cephalosporins.
January 7, 2021: Clinical Infectious Diseases
journal
journal
20074
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"